NSE:INDSWFTLAB Ind-Swift Laboratories Ltd. engages in the manufacture, development, and marketing of pharmaceutical ingredients. The firm operates throughout India and Outside India's geographical segments. Its products include API's and impurities. The firm supplies active pharmaceutical ingredients to pharmaceutical companies and also provides research and...
NSE:AARTIIND Long Trade in Aarti industries. Best Buy ; Above 530+ Stop Loss: 490 Targets: 570/650/740/800/850/900+++ Reasons to Buy: Breakout of Falling Wedge pattern. Breakout with a good volume candle. Above 530 there is good support from 200dma. Good Risk to Reward Ratio. Thanks & Happy Trading Disclaimer: This idea is only for...
Analysis: The chart of Granules India on TradingView suggests a promising breakout opportunity, potentially signaling a long entry chance for traders. Let's analyze the details based on the information provided on chart. Current Price: ₹455.75, above the old year resistance level of ₹436.20 marked by the orange line. Breakout Confirmation: The recent surge...
Analysis: The chart of Natco Pharma Ltd. on TradingView depicts an intriguing post-breakout scenario, presenting both potential long entry and cautious approaches for traders. Let's dissect the situation: Current Price : ₹1026.50, well above the multi-year resistance level of ₹921.10 marked by the orange line. Breakout Confirmation: The recent surge past...
Analysis: The provided chart of SMS Pharmaceuticals (SMS Pharma) on TradingView reveals a potentially lucrative breakout opportunity. Let's break it down: Current Price: ₹145.45, comfortably above the multi-year resistance level of ₹136 marked by the blue line. Breakout Confirmation: The recent surge past the resistance zone, accompanied by strong volume,...
KOPRAN looks good as it's moving up with the volume and as per the sentiments, PHARMA related stocks are in buzz. Expecting 20-30% easily above this zone.
1. stock breakout resistance level almost 8th time 2. stock retest and create mini flag pattern (10.1.24 goods for interday) 3. stock close high price with green candle 4. volume also build 5. 1329 stock higher price since 6. entry should be 1330 7. target as per you planing for my side 4% first target 8. Stop loss should resistance level where stock give breakout
SPARC is trading near support and volume is coming in this stock. Price is at an attractive area. Targets 250-290-300-320-350
Bullish trend on the Charts cup and handle pattern on a weekly time frame bullish trend on the charts and target as marked for medium to long term holdings will take entry in Monday
Laurus Labs Ltd | Pharma multibagger momentum stock Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) Financial: excellent Market Cap = 23,185 Cr. ROCE = 22.2 % ROE = 20.4 % Debt to equity = 0.45 Promoter holding =...
PE is negative at -42 THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over...
Weekly Timeframe is bullish Daily Timeframe has tested demand zone Structure is shifted from bearish to bullish on 4HR Not to be considered as financial advice. Just a personal outlook
It gave a breaout after a good consolidation and retested it also with a good hammer candle and also it is in a good uptrend which shows strength in this stock.
Cipla, the price is trading below the long-term group of ema's also we have a bearish cross of ema bands. The degree and nature of separation of both bands indicates price consolidation on these levels. So, we use Darvas Box to trade the instrument. Short Trade Setup The breakdown of 1145 will open the lower levels of 1080 which is about 5% Also we have a...
My View on Sun pharma After Breakout Poll & Flag Patter and now Retest on Trendline. So Buy for good profit. My Target 1275 till Oct-23 End
AJANTPHARM, a leading pharmaceutical company, has recently seen its stocks take a dip, positioning perfectly into the EMA 20 strategy that I'm about to unveil. Before we dive into our analysis, let's ensure we understand the strategy. 📚 The EMA 20 Strategy Explained Identify an Uptrend: Look for a Higher High-Higher Low structure. Ensure the EMA 8 lies...
Biocon 1.if Price will close above 265, Price will go Target 1.
Trend Changed Divis Lab Target 1 4400s Target 2 4950 Stop Loss 3500s